Anavex Life Sciences Corp (AVXL)

[Steady_T]

2-73 will certainly knock the 2 recently approved mabs off the market and that represents many tens of millions of Dollars of R&D costs that will go down the drain.

Rett will put a big dent in Trofinetide sales if it doesn't knock it off the market..

There are three companies right there that stand to lose a lot of money when 2-73 succeeds.

And then there is that very large amount of money on the short side. Many tens of millions of $ at stake there.

So, yes there are entities that have a huge stake in seeing Anavex fail or at the least be delayed as much as possible.
Business at this level is cutthroat.